<DOC>
	<DOCNO>NCT02154269</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness treatment G-CSF patient chronic heart failure secondary Chagas disease .</brief_summary>
	<brief_title>Evaluation G-CSF ( Colony Stimulating Factor ) Patients With Chronic Chagas Cardiomyopathy</brief_title>
	<detailed_description />
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Chagas Cardiomyopathy</mesh_term>
	<mesh_term>Myocarditis</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Diagnosis Chagas ' disease confirm two serological test different methodology ; Diagnosis Chagas ' cardiomyopathy NYHA functional class II , III IV heart failure ; Availability willingness participate , give schedule study ; Agreement sign write form . Acute systemic infection Solid neoplasms , myelodysplastic syndrome , acute chronic myeloid leukemia , confirm image study past medical history ; Valvulopathies hemodynamic consequence ; Autoimmune , pulmonary , degenerative disease , confirm image study past medical history ; Severe renal , hepatic thyroid dysfunction , confirm image study past medical history ; Pregnancy ( confirm examination Î² HCG ) lactation ; Known hypersensitivity GCSF component formula / hypersensitivity proteins derive E. coli .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Chagas disease</keyword>
	<keyword>G-CSF</keyword>
	<keyword>Cell therapy</keyword>
</DOC>